Methadone and buprenorphine treatments in patients with schizophrenia
- 14 May 2019
- journal article
- letter
- Published by Elsevier in Schizophrenia Research
- Vol. 209, 286-288
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. populationDrug and Alcohol Dependence, 2011
- Substance Use Disorders in Schizophrenia--Clinical Implications of ComorbiditySchizophrenia Bulletin, 2009
- Clinical characteristics influencing age at onset in psychotic disordersComprehensive Psychiatry, 2009
- Substance abuse and first‐episode schizophrenia‐spectrum disorders. The Danish OPUS trialEarly Intervention in Psychiatry, 2007
- Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosisThe British Journal of Psychiatry, 2007
- Substance abuse in first-episode non-affective psychosisSchizophrenia Research, 2006
- Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addictionSchizophrenia Research, 2006
- Psychotic symptom and cannabis relapse in recent-onset psychosisThe British Journal of Psychiatry, 2006
- Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequencesSchizophrenia Research, 2004
- Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical CorrelatesSchizophrenia Bulletin, 1990